Nurix Therapeutics Inc reports results for the quarter ended in February - Earnings Summary

Nurix Therapeutics

11/04/2024 22:01

* Nurix Therapeutics Inc  NRIX.OQ  reported a quarterly
adjusted
loss of 76 cents​​ per share for the quarter ended in February,
lower than the same quarter last year, when the company reported
EPS of -75 cents.  The mean expectation of ten analysts for the
quarter was for a loss of 80 cents per share. Wall Street
expected results to range from -95 cents to -64 cents per share.
    * Revenue rose 30.7% to $16.59 million from a year ago;
analysts
expected $16.64 million. 
    * Nurix Therapeutics Inc's reported EPS for the quarter was
a loss
of 76 cents​.
    * The company reported a quarterly loss of $41.52 million.
    * Nurix Therapeutics Inc shares had risen by 6.7% this
quarter and
gained 52.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Nurix
Therapeutics Inc is $23.50 
This summary was machine generated from LSEG data April 11 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Feb. 29 2024      -0.80          -0.76          Beat
 Nov. 30 2023      -0.57          -0.77          Missed
 Aug. 31 2023      -0.76          -0.68          Beat
 May. 31 2023      -0.56          -0.45          Beat